N. Fraunhoffer

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

N. Fraunhoffer

Oct 16, 2024, 14:54 | Insight

Nelson Dusetti: Guiding treatment decisions for operable and metastatic patients with PDAC

Nelson Dusetti posted on X: "We discuss here the dual resistance to mFOLFIRINOX and gemcitabine, the…

Jul 24, 2024, 22:22 | Insight

Nelson Dusetti: One of the first publications from the Franco-Argentine Network for Pancreatic Cancer

Nelson Dusetti shared a post on LinkedIn: "We are thrilled to announce one of the…

All: 2 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023